Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
309.3 USD | -0.04% | -1.54% | +7.59% |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
05-22 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.59% | 166B | |
+37.98% | 723B | |
+34.08% | 595B | |
-2.87% | 369B | |
+20.30% | 332B | |
+2.65% | 282B | |
+16.96% | 244B | |
+9.51% | 208B | |
-4.70% | 205B | |
+0.80% | 168B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- RBC Lifts Price Target on Amgen to $224 From $223, Maintains Sector Perform Rating